n,n-dipropylcarboxamidotryptamine has been researched along with ici 118551 in 1 studies
Studies (n,n-dipropylcarboxamidotryptamine) | Trials (n,n-dipropylcarboxamidotryptamine) | Recent Studies (post-2010) (n,n-dipropylcarboxamidotryptamine) | Studies (ici 118551) | Trials (ici 118551) | Recent Studies (post-2010) (ici 118551) |
---|---|---|---|---|---|
23 | 0 | 5 | 836 | 31 | 106 |
Protein | Taxonomy | n,n-dipropylcarboxamidotryptamine (IC50) | ici 118551 (IC50) |
---|---|---|---|
Beta-2 adrenergic receptor | Homo sapiens (human) | 0.0007 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, IK; Gardiner, SM; Ramage, AG | 1 |
1 other study(ies) available for n,n-dipropylcarboxamidotryptamine and ici 118551
Article | Year |
---|---|
Cardiovascular effects of serotonin and DP-5-CT in conscious Long-Evans and Brattleboro rats.
Topics: Adrenergic beta-Antagonists; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Cardiovascular System; Hemodynamics; Hormone Antagonists; Injections, Intraventricular; Male; Propanolamines; Rats; Rats, Brattleboro; Rats, Inbred Strains; Serotonin; Serotonin Receptor Agonists; Sodium Chloride; Tryptamines | 1996 |